UNC Lineberger awarded up to $28M to develop an adaptive clinical trial for metastatic breast cancer - UNC Lineberger
UNC Lineberger will lead the development of a next-generation clinical trial for metastatic breast cancer. The new trial design will adapt treatment plans in near real-time by analyzing changes in each patient’s cancer and matching it to the most promising therapy.| UNC Lineberger
